Financial Performance - The company's operating revenue for Q1 2024 was ¥755,826,600.84, representing a decrease of 7.53% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥115,658,977.23, down 11.85% year-on-year[5]. - The net profit after deducting non-recurring gains and losses increased by 37.35% to ¥131,190,922.46, primarily due to the recovery of receivables[5][8]. - The basic and diluted earnings per share were both ¥0.07, reflecting an 11.85% decline[5]. - Net profit for Q1 2024 was ¥113.89 million, a decline of 14.77% compared to ¥133.59 million in Q1 2023[19]. - The company achieved a basic and diluted earnings per share of CNY 0.15 in Q1 2024, compared to CNY 0.00 in Q1 2023, marking a return to profitability[29]. - The total comprehensive income for the period was CNY 244,977,271.91, compared to CNY 3,215,597.90 in the previous year, indicating a substantial increase[29]. Cash Flow - The net cash flow from operating activities was ¥6,093,793.47, an increase of 6.45% compared to the previous year[5]. - Cash flow from operating activities for Q1 2024 was ¥6.09 million, slightly up from ¥5.72 million in Q1 2023[22]. - The company's net cash flow from investment activities for Q1 2024 was ¥530,315,704.34, compared to a negative cash flow of ¥128,872,463.73 in Q1 2023, indicating a significant improvement[23]. - In Q1 2024, the company reported a net cash flow from operating activities of CNY 468,058,733.08, a significant increase from CNY 7,137,565.57 in Q1 2023, representing a growth of approximately 6,563%[31]. - The total cash inflow from operating activities was CNY 1,539,883,479.22, compared to CNY 1,072,172,536.08 in the same period last year, indicating a year-over-year increase of about 43.5%[31]. - The net cash flow from investment activities was CNY 3,280,217.90, a recovery from a negative cash flow of CNY 10,475,586.95 in the previous year[32]. Assets and Liabilities - Total assets at the end of the reporting period were ¥10,464,604,592.16, a decrease of 6.08% from the end of the previous year[6]. - The company's total assets amounted to RMB 10,464,604,592.16, a decrease from RMB 11,142,420,839.14 at the end of 2023, reflecting a decline of approximately 6.08%[14]. - The company's total liabilities as of March 31, 2024, were ¥4,446,558,948.72, slightly down from ¥4,554,031,643.87 at the end of 2023[27]. - Total liabilities as of Q1 2024 were ¥4.23 billion, down from ¥5.01 billion in the previous year[16]. - The company's total current liabilities decreased to RMB 4,000,000.00 in short-term borrowings, unchanged from the previous period[15]. Shareholder Equity - Shareholders' equity attributable to the parent company increased by 1.79% to ¥6,300,646,159.74[6]. - Total equity attributable to shareholders was ¥6.30 billion in Q1 2024, compared to ¥6.19 billion in Q1 2023[16]. - The total equity of the company as of March 31, 2024, was ¥5,937,200,616.46, an increase from ¥5,711,772,430.44 at the end of 2023, indicating a strengthening financial position[27]. Operational Metrics - The total number of ordinary shareholders at the end of the reporting period was 71,684[10]. - The company's cash and cash equivalents increased to RMB 2,612,349,072.28 from RMB 2,575,128,503.33, showing a growth of about 1.04%[14]. - Accounts receivable rose significantly to RMB 486,760,918.58, up from RMB 350,588,892.40, representing an increase of approximately 38.76%[14]. - Inventory levels remained stable at RMB 2,244,504,044.27, slightly increasing from RMB 2,236,792,461.22, indicating a marginal growth of 0.34%[14]. - The company's inventory as of March 31, 2024, was ¥1,072,651,178.29, an increase from ¥962,513,656.31 at the end of 2023, suggesting potential growth in sales or production[26]. Investment and Expenses - The company reported a significant increase in investment income for Q1 2024, amounting to ¥196,648,515.87, compared to ¥7,634,314.17 in Q1 2023, highlighting improved investment performance[28]. - The company reported a decrease in research and development expenses to ¥25.23 million in Q1 2024 from ¥48.61 million in Q1 2023[18]. - Research and development expenses for Q1 2024 were ¥25,225,661.48, significantly lower than ¥48,609,057.34 in Q1 2023, indicating a strategic shift in R&D investment[28].
腾达建设(600512) - 2024 Q1 - 季度财报